Climedo

The leading European #eCOA system for non-interventional studies, RWE & launch success.

Industries: #Pharma #MedTech #CROs
Solutions: #EDC #ePRO #eConsent

[Climedo @ClimedoHealth]

43 neue Medikamente in Deutschland zugelassen, davon 27 für seltene Erkrankungen – ein Fortschritt für Patient:innen! Auch RSV-Impfstoffe & Reserveantibiotika dabei. Trotzdem bleibt Handlungsbedarf bei Antibiotika-Resistenzen.

Mehr im @Dt_Aerzteblatt: https://t.co/dSG17br8az

[Climedo @ClimedoHealth]

Missed our Climedo Connect on DTx back in September? Now’s your chance to catch up!

🎥 Watch the webinar on demand now https://t.co/noYbHpVRa2

#DigitalTherapeutics #DTx #HealthcareInnovation #ClimedoConnect

[Climedo @ClimedoHealth]

Revolutionizing Clinical Trials with Digital Twins. With the market for digital twins in clinical trials projected to grow from $1.17 billion in 2022 to $38.43 billion by 2032, this technology is set to accelerate breakthroughs in personalized medicine. https://t.co/DBcVBK2Tn7

[Climedo @ClimedoHealth]

Missed our #ClimedoConnect webinar back in Oct? Watch the on-demand session to explore how combining Patient Centricity with Real-World Evidence (RWE) is transforming healthcare: https://t.co/nmPELFF5rm

[Climedo @ClimedoHealth]

🌟 Early cineole use can significantly reduce common cold symptoms & recovery time. 📉 Patients treated within 12h saw a 38% lower symptom burden. Data captured seamlessly via Climedo's eDiary ensured real-time, accurate insights. https://t.co/hCOyWDTK3h

[Climedo @ClimedoHealth]

Unstructured data in #RWE studies is no longer a challenge—thanks to #GenAI! 🌟

Discover how GenAI is transforming clinical notes, patient feedback & more into actionable insights. Faster, smarter, better healthcare outcomes await.

🧠 Learn more: https://t.co/5RamKmoEpB

[Climedo @ClimedoHealth]

Breaking Barriers to Access in Oncology
📊 Faster decisions in some EU markets
⏳ Delays persist for combo therapies in others
🔬 RWE & mature data key to success
IQVIA's ISPOR EU 2024 study reveals trends in patient access to innovation across UK & EU.
https://t.co/6i1TJGz51Z

[Climedo @ClimedoHealth]

This International Women’s Day 2025, we’re stepping forward in solidarity to help #AccelerateAction for gender equality.

Join us on March 8 and take decisive steps to accelerate the momentum for change. 🌍💜

[Climedo @ClimedoHealth]

Why KOL Engagement Matters in Phase IV Trials
💡 Build trust through open dialogue
📊 Share real-time data via dashboards
🔬 Involve KOLs in cutting-edge discoveries
Engage effectively to boost credibility, data collection and patient access to treatments
https://t.co/VHqNsOA3is

[Climedo @ClimedoHealth]

This #RareDiseaseDay, Climedo supports innovative treatments for rare diseases with cutting-edge clinical trial solutions. Let’s unite for the 300M people living with rare diseases and advocate for equity in healthcare and diagnosis. 💙💚💜
#ClinicalTrials #EquityForRareDiseases

[Climedo @ClimedoHealth]

Just 1 week to go before we discuss omnichannel innovation for rare disease Medical Affairs in our #ClimedoConnect with @novonordisk – join us on February 26 to talk about crafting omnichannel strategies for rare disease medical affairs: https://t.co/vB2HQV9hsY

[Climedo @ClimedoHealth]

Getting Drugs to Patients Faster.
Colleen Dixon: Pharma 4.0 + AI = streamlined processes & faster tech transfer 🚀
Mary Lou Glotzbach: Patient-centric delivery + sustainability 🌍
Learn more via @medicine_maker
https://t.co/Skm2hixsUT

[Climedo @ClimedoHealth]

In case you missed one of our top blog posts last year on our trial physician survey results – here's a quick recap. 🔍
https://t.co/iy85hsaN5x

[Climedo @ClimedoHealth]

Eine Umfrage zeigt: 2/3 der Ärzte sehen KI als Schlüssel für bessere Versorgung und Entlastung. Doch es besteht großer Weiterbildungsbedarf – gerade bei Haftungsfragen und Kontrollverlust.

Mehr dazu im @Dt_Aerzteblatt: https://t.co/PmgnYydCfU

[Climedo @ClimedoHealth]

Ready to take your HCP engagement to the next level? Join us on February 26, 2025, at 3 PM CET for an exclusive webinar: "Connecting the Dots: Omnichannel Engagement in Rare Disease Medical Affairs." https://t.co/bEV3Rkd6ym

[Climedo @ClimedoHealth]

It's #WorldCancerDay.

💙 Join us this February 4 as we stand together for a future where cancer care is about more than just treatment—it’s about people.

[Climedo @ClimedoHealth]

Generative AI could cut costs, save time, & increase equity in clinical trials. 5 possibilities:
1️⃣ Faster trial design
2️⃣ Smarter site selection
3️⃣ Diverse patient recruitment
4️⃣ Automated data analysis
5️⃣ Streamlined regulatory submission
https://t.co/wVfZdYDRCC

[Climedo @ClimedoHealth]

In her guest blog post, Patient Expert Clarinda Cerejo describes the meaning of empathy in a clinical context, why it is missing in clinical interactions and whether empathy can be taught. She also looks at the role of AI. Read her full blog post here: https://t.co/vQlYwuJ8sA

[Climedo @ClimedoHealth]

💡 Building Responsible AI in Healthcare 💡

A new case study from the Mass General Brigham AI Governance Committee offers a blueprint for integrating artificial intelligence (AI) into healthcare responsibly.
https://t.co/7p6XpfE8nX

[Climedo @ClimedoHealth]

How can medical affairs teams meet HCPs’ rising expectations for connected communication while optimizing ROI? The answer lies in omnichannel engagement. Don’t miss our upcoming webinar on February 26: https://t.co/4LKG00IaPw